Purchases and Sales Made in Q1 2023 in Acurx Pharmaceuticals, Inc. (ACXP)
This table provides information about the institutional ownership of Acurx Pharmaceuticals, Inc. (ACXP) during Q1 2023. The information is specifically focused on institutions that hold shares of Acurx Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
89.5KNew |
$274K - $403K
|
89.5K
$149K
|
|
May 12, 2023
Q1 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
4K+ 33.33% |
$12.2K - $18K
|
16K
$26.7K
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
522+ 3.34% |
$1.6K - $2.35K
|
16.2K
$27K
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
168+ 6.14% |
$514 - $756
|
2.9K
$4.85K
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 1.64% |
$3.06 - $4.5
|
62
$104
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-5- 0.17% |
$15.3 - $22.5
|
2.89K
$4.83K
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-7.05K- 24.21% |
$21.6K - $31.7K
|
22.1K
$36.8K
|
|
May 15, 2023
Q1 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-600K- 68.18% |
$1.84M - $2.7M
|
280K
$468K
|